secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2023-08-16T23:59:59+00:00
Accession:  0001437749-23-023954
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife execs to receive up to 100% of base salary in stock through Dec 2023
----------------------------------------------------------------------------

- CEO Michael Rice to receive 50% of base salary in vested shares for Aug 14-Dec 31, 2023; 50% in cash.
- EVP Aby Mathew to receive 100% of base salary in shares; CFO and COO to receive 30% in shares.
- All board members will receive all remaining 2023 cash compensation in fully vested shares.
- Compensation reverts to full cash payment on January 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000143774923023954/0001437749-23-023954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000143774923023954/bioli20230816_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-023954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer